Genetic diagnostics of early childhood hearing loss: Better testing with Next-Generation DNA Sequencing

B-ENT

Volumn , Issue SUPPL. 21, 2013, Pages 51-56

  Sommen, M ^a   Van Camp, G ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Congenital hearing loss; Deafness; Genetics and diagnostics

Indexed keywords

ARTICLE; CHILDHOOD DISEASE; DIAGNOSTIC TEST; DNA SEQUENCE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HEARING IMPAIRMENT; HUMAN; MUTATION RATE; COST BENEFIT ANALYSIS; GENETICS; HEARING LOSS; INFANT; NEWBORN; NEWBORN SCREENING; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; GENETIC TESTING; HEARING LOSS; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 84890294414     PISSN: 1781782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Morton CC, Nance WE. Newborn hearing screening-a silent revolution. N Engl J Med. 2006;354(20):2151-2164.
2. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sei. 1991;630:16-31.
3. Marazita ML, Ploughman LM, Rawlings B, Remington E, Amos KS, Nance WE. Genetic epidemiological studies of early-onset deafness in the U. S. school-age population. Am J Med Genet. 1993;46(5):486-491.
4. Smith RJ, Bale JF Jr., White KR. Sensorineural hearing loss in children. Lancet. 2005;365(9462):879-890.
5. Cryns K, Van Camp G. Deafness genes and their diagnostic applications. Audiol Neurootol. 2004;9(1):2-22.
6. Hilgert N, Smith RJ, Van Camp G. Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res. 2009;681(2-3):189-196.
7. Putcha GV, Bejjani BA, Bleoo S, Booker JK, Carey JC, Carson N, Das S, Dempsey MA, Gastier-Foster JM, Greinwald JH, Jr., Hoffmann ML, Jeng LJ, Kenna MA, Khababa I, Lilley M, Mao R, Muralidharan K, Otani IM, Rehm HL, Schaefer F, Seltzer WK, Spector EB, Springer MA, Weck KE, Wenstrup RJ, Withrow S, Wu BL, Zariwala MA, Schrijver I. A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort. Genet Med. 2007;9(7):413-426.
8. Snoeckx RL, Huygen PL, Feldmann D, Marlin S, Denoyelle F, Waligora J, Mueller-Malesinska M, Poliak A, Ploski R, Murgia A, Orzan E, Castorina P, Ambrosetti U, Nowakowska-Szyrwinska E, Bai J, Wiszniewski W, Janecke AR, Nekahm-Heis D, Seeman P, Bendova O, Kenna MA, Frangulov A, Rehm HL, Tekin M, Incesulu A, Dahl HH, Du Sart D, Jenkins L, Lucas D, Bitner-Glindzicz M, Avraham KB, Brownstein Z, Del Castillo I, Moreno F, Blin N, Pfister M, Sziklai I, Toth T, Kelley PM, Cohn ES, Van Maldergem L, Hilbert P, Roux AF, Mondain M, Hoefsloot LH, Cremers CW, Lopponen T, Lopponen H, Parving A, Gronskov K, Schrijver I, Roberson J, Gualandi F, Martini A, Lina-Granade G, Pallares-Ruiz N, Correia C, Fialho G, Cryns K, Hilgert N, Van De Heyning P, Nishimura CJ, Smith RJ, Van Camp G. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet. 2005;77(6):945-957.
9. Fraser GR. Association of Congenital Deafness with Goitre (Pendred's Syndrome) a Study of 207 Families. Ann Hum Genet. 1965;28:201-249.
10. Reardon W, O'Mahoney CF, Trembath R, Jan H, Phelps PD. Enlarged vestibular aqueduct: a radiological marker of pendred syndrome, and mutation of the PDS gene. QJM. 2000;93(2):99-104.
11. Sinnathuray AR, Toner JG, Clarke-Lyttle J, Geddis A, Patterson CC, Hughes AE. Connexin 26 (GJB2) generelated deafness and speech intelligibility after cochlear implantation. Otol Neurotol. 2004;25(6):935-942.
12. Chiong C, Ostrea E Jr., Reyes A, Llanes EG, Uy ME, Chan A. Correlation of hearing screening with developmental outcomes in infants over a 2-year period. Acta Otolaryngol. 2007;127(4):384-388.
13. Fitzpatrick E, Durieux-Smith A, Eriks-Brophy A, Olds J, Gaines R. The impact of newborn hearing screening on communication development. J Med Screen. 2007;14(3):123-131.
14. Graven SN, Browne JV. Auditory Development in the Fetus and Infant. Newborn Infant Nurs Rev. 2008;8(4):187-193.
15. Bauer PW, Geers AE, Brenner C, Moog JS, Smith RJ. The effect of GJB2 allele variants on performance after cochlear implantation. Laryngoscope. 2003;113(12):2135-2140.
16. Sinnathuray AR, Toner JG, Geddis A, Clarke-Lyttle J, Patterson CC, Hughes AE. Auditory perception and speech discrimination after cochlear implantation in patients with connexin 26 (GJB2) gene-related deafness. Otol Neurotol. 2004;25(6):930-934.
17. Taitelbaum-Swead R, Brownstein Z, Muchnik C, Kishon-Rabin L, Kronenberg J, Megirov L, Frydman M, Hildesheimer M, Avraham KB. Connexin-associated deafness and speech perception outcome of cochlear implantation. Arch Otolaryngol Head Neck Surg. 2006;132(5):495-500.
18. Harrison M, Roush J, Wallace J. Trends in age of identification and intervention in infants with hearing loss. Ear Hear. 2003;24(1):89-95.
19. De Leenheer EM, Janssens S, Padalko E, Loose D, Leroy BP, Dhooge IJ. Etiological diagnosis in hearing impaired newborn: proposal of a flow chart. Int J Pediatr Otorhinolaryngol. 2011;75:27-32.
20. Matsunaga T. Value of genetic testing in the otological approach for sensorineural hearing loss. Keio J Med. 2009;58(4):216-222.
21. Choi BO, Koo SK, Park MH, Rhee H, Yang SJ, Choi KG, Jung SC, Kim HS, Hyun YS, Nakhro K, Lee HJ, Woo HM, Chung KW. Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease. Hum Mutat. 2012;33(11):1610-1615.
22. Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, Schork NJ, Murray SS, Topol EJ, Levy S, Frazer KA. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol. 2009;10(3):R32.
23. Hilgert N, Van Camp G. DNA diagnostics for children with hearing loss. Tijdschrijft van de Belgische Kinderarts. 2008;10:56-60.
24. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci U S A. 2010;107(49):21104-21109.
25. Brownstein Z, Friedman LM, Shahin H, Oron-Kami V, Kol N, Abu Rayyan A, Parzefall T, Lev D, Shalev S, Frydman M, Davidov B, Shohat M, Rahile M, Lieberman S, Levy-Lahad E, Lee MK, Shomron N, King MC, Walsh T, Kanaan M, Avraham KB. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol. 2011;12(9):R89.
26. Tang W, Qian D, Ahmad S, Mattox D, Todd NW, Han H, Huang S, Li Y, Wang Y, Li H, Lin X. A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach. Genet Test Mol Biomarkers. 2012;16(6):536-542.
27. De Keulenaer S, Hellemans J, Lefever S, Renard JP, De Schrijver J, Van De Voorde H, Tabatabaiefar MA, Van Nieuwerburgh F, Flamez D, Pattyn F, Scharlaken B, Deforce D, Bekaert S, Van Criekinge W, Vandesompele J, Van Camp G, Coucke P. Molecular diagnostics for congenital hearing loss including 15 deafness genes using a next generation sequencing platform. BMC Med Genomics. 2012;5:17.
28. Schrauwen I, Sommen M, Comeveaux JJ, Reiman RA, Hackett NJ, Claes C, Claes K, Bitner-Glindzicz M, Coucke P, Van Camp G, Huentelman MJ. A sensitive and specific diagnostic test for hearing loss using a microdroplet PCR-based approach and next generation sequencing. Am J Med Genet A. 2013;161 A(1):145-152.
29. Mamanova L, Coffey AJ, Scott CE, Kozarewa I, Turner EH, Kumar A, Howard E, Shendure J, Turner DJ. Targetenrichment strategies for next-generation sequencing. Nat Methods. 2010;7(2):111-118.
30. Huentelman MJ. Targeted next-generation sequencing: microdroplet PCR approach for variant detection in research and clinical samples. Expert Rev Mol Diagn. 2011;11(4):347-349.